Adoptive transfer of tumor infiltrating lymphocytes (TILs) into the autologous patient with melanoma resulted in the objective regression of tumor, suggesting t
Antigen-nonspecific approaches to the use of BRMs for cancer treatment have resulted inonly limited success to date. Recent demonstrations of T-Iymphocyte-media